Sage Therapeutics Inc (NASDAQ: SAGE) open the trading on Wednesday, with a bit cautious approach as it glided -0.23% to $8.68, before settling in for
A new trading day began on Friday, with Sage Therapeutics Inc (NASDAQ: SAGE) stock price up 0.46% from the previous day of trading, before settling
A new trading day began on Tuesday, with Sage Therapeutics Inc (NASDAQ: SAGE) stock price down -2.45% from the previous day of trading, before settling
Sage Therapeutics Inc (NASDAQ: SAGE) on Friday, soared 0.65% from the previous trading day, before settling in for the closing price of $9.21. Within the
A new trading day began on Tuesday, with Sage Therapeutics Inc (NASDAQ: SAGE) stock price down -0.11% from the previous day of trading, before settling
On Monday, Sage Therapeutics Inc (NASDAQ: SAGE) was 35.37% up from the session before settling in for the closing price of $6.70. A 52-week range
Sage Therapeutics Inc (NASDAQ: SAGE) started the day on Thursday, with a price increase of 3.67% at $6.78, before settling in for the price of
During the past 52 weeks, Sage Therapeutics (SAGE) shares have fallen about 25%. Another reason for the decline in quotations is the drug’s inability to
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.